脑机接口临床应用加速， 光莆股份、 泰和科技 前景可期

Group 1 - The first clinical application of brain-computer interface (BCI) technology in China has been successfully performed, marking a new phase in its clinical application [1] - The surgery was conducted at Huazhong University of Science and Technology's Tongji Hospital and is the first BCI operation priced according to government-approved medical service pricing [1] - The invasive BCI implantation fee is set at 6,552 yuan per procedure, excluding the cost of the BCI device, indicating a significant step towards the commercialization and accessibility of this technology [1] Group 2 - Paradromics, a US-based BCI company, has received FDA approval to conduct its first long-term clinical trial for its brain-computer interface [2] - The trial aims to explore the ability to accurately detect neural activity when volunteers imagine hand movements, potentially allowing them to control a computer cursor with their thoughts [2] - Initial results suggest the trial may expand to include 10 volunteers, who will receive two cortical implants to enhance signal richness and cover more brain areas [2]